🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Immunovia AB (publ) (STO:IMMNOV)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0371
+0.0042 (12.77%)
Nov 19, 2026, 2:14 PM CET

Immunovia AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1.950.690.931.581.150.84
1.950.690.931.581.150.84
Revenue Growth
148.79%-26.42%-40.89%37.55%35.66%133.15%
Cost of Revenue
0.790.14-6.684.21-14.97
Gross Profit
1.160.550.93-5.11-3.0715.81
Selling, General & Admin
73.6477.7394.48148.3162.97162.09
Other Operating Expenses
0.140.953.211.560.261.4
Operating Expenses
76.6581111.11291.58188.14182.55
Operating Income
-75.49-80.45-110.17-296.69-191.21-166.74
Interest Expense
--2.04-1.86-1.17-1.6-1.43
Interest & Investment Income
63.20.5434.736.280.750.71
Currency Exchange Gain (Loss)
-63.96-63.960.76-17.8723.9711.5
Other Non Operating Income (Expenses)
0.05--0.01--
EBT Excluding Unusual Items
-76.2-145.92-76.54-309.44-168.09-155.97
Pretax Income
-76.2-145.92-76.54-309.44-168.09-155.97
Net Income
-76.2-145.92-76.54-309.44-168.09-155.97
Net Income to Common
-76.2-145.92-76.54-309.44-168.09-155.97
Net Income Growth
------
Shares Outstanding (Basic)
64634483392323
Shares Outstanding (Diluted)
64634483392323
Shares Change
164.13%316.79%112.20%72.02%-6.05%
EPS (Basic)
-0.12-0.42-0.93-7.95-7.43-6.89
EPS (Diluted)
-0.12-0.42-0.93-7.95-7.43-6.89
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-76.15-78.4-96.75-147.06-176.84-155.75
Free Cash Flow Per Share
-0.12-0.23-1.17-3.78-7.81-6.88
Gross Margin
59.40%80.15%100.00%--267.77%1873.58%
Operating Margin
-3865.08%-11744.82%-11833.94%-18837.27%-16699.48%-19756.04%
Profit Margin
-3901.59%-21301.46%-8221.38%-19646.92%-14680.52%-18479.38%
Free Cash Flow Margin
-3899.28%-11445.26%-10392.37%-9336.95%-15444.37%-18453.67%
EBITDA
-74.9-80.41-108.43-167.63-185.15-161.1
D&A For EBITDA
0.580.041.75129.056.065.64
EBIT
-75.49-80.45-110.17-296.69-191.21-166.74
Revenue as Reported
2.070.751.691.81.20.96